THE PROGNOSTIC VALUE OF TUMOR-ASSOCIATED CARBOHYDRATE STRUCTURES CORRELATED WITH GENE AMPLIFICATIONS IN HUMAN BREAST CARCINOMAS

被引:17
作者
FUKUTOMI, T
HIROHASHI, S
TSUDA, H
NANASAWA, T
YAMAMOTO, H
ITABASHI, M
SHIMOSATO, Y
机构
[1] The Department of Surgery, National Cancer Center Hospital, Tokyo, 104, 1-1, Tsukiji, 5-chome, Chuo-ku
[2] Pathology Division, National Cancer Center Research Institute, Tokyo
来源
JAPANESE JOURNAL OF SURGERY | 1991年 / 21卷 / 05期
关键词
BREAST CARCINOMA; PROGNOSTIC FACTOR; HPA; C-ERB B-2; ST-439;
D O I
10.1007/BF02470985
中图分类号
R61 [外科手术学];
学科分类号
摘要
The effects of cell surface sugar chains combined with certain gene amplifications of breast cancers on the prognosis of patients were studied and the relationships between the sugar chains of cancer cells and amplifications of the proto-oncogenes c-myc, int-2 and c-erb B-2, evaluated. One hundred and fifty three human breast carcinoma tissues were investigated by an immunohistochemical technique using the avidinbiotin-peroxidase method with 1 lectin (HPA; Helix Pomatia) and 4 monoclonal antibodies (B-72-3, St-439, anti-Tn and anti-T). The positive rates of HPA, St-439, B-72-3, anti-Tn and anti-T were 43 per cent (63/153), 52 per cent (80/153), 53 per cent (81/153), 64 per cent (98/153) and 89 per cent (136/153), respectively. Patients whose cancers had positive HPA staining were found to have a lower survival rate than those with negative HPA staining (p < 0.05), whereas those whose cancers had positive St-439 staining showed a better prognosis than those with negative St-439 staining (p < 0.01). The positive rate of HPA was related to the gene amplification of c-myc proto-oncogene (p < 0.01), whereas the negative rate of St-439 was correlated with the gene amplification of c-erb B-2 (p < 0.01). These data indicate the prognostic value of HPA and St-439 and also the relationships between the gene amplifications and carbohydrate structures in breast cancer cells.
引用
收藏
页码:499 / 507
页数:9
相关论文
共 31 条
[1]  
Nicolson G.L., Cancer metastasis. Organ colonization and the cell surface properties of malignant cells, Biochem Biophys Acta, 695, pp. 129-142, (1982)
[2]  
Werwer U., Taraboletti G., Sobel M.E., Sobel M.E., Albrectsen R., Liotta L.A., Role of laminin receptor in tumor cell migration, Cancer Res, 47, pp. 5691-5698, (1987)
[3]  
Steck R.A., Nicolson G.L., Cell surface glycoprotein of 13762 NF mammary adenocarcinoma clones of differing metastatic potentials, Experimental Cell Res, 147, pp. 255-267, (1983)
[4]  
Altevogt P., Fogel M., Cheingsong-Popov R., Dennis J., Robinson P., Schirrmacher V., Different patterns of lectin binding and cell surface sialylation detected on related high and low metastatic tumor lines, Cancer Res, 43, pp. 5138-5144, (1983)
[5]  
Takahashi H.K., Metoki R., Hakomori S., Immunoglobulin G3 monoclonal antibody directed to Tn antigen (Tumor-associated-N-acetylgalactosaminyl epitope) that does not cross-react with Blood group A antigen, Cancer Res, 48, pp. 4361-4367, (1988)
[6]  
Seitz R.C., Fischer K., Stegner H.E., Poschmann A., Detection of metastatic breast carcinoma cells by immunofluorescent demonstration of Thomsen-Friedenreich antigen, Cancer, 54, pp. 830-836, (1984)
[7]  
Kjeldsen T., Clausen H., Hirohashi S., Ogawa T., Iijima H., Hakomori S., Preparation and characterization of monoclonal antibodies directed to the tumor-associated 0-linked sialosyl-2-6-N-acetylgal-actosaminyl (sialosyl-Tn) epitope, Cancer Res, 48, pp. 2214-2220, (1988)
[8]  
Watanabe M., Hirohashi S., Shimosato Y., Ino Y., Yamada T., Teshima S., Sekine T., Abe O., Carbohydrate antigen defined by a monoclonal antibody raised against a gastric cancer xenograft, Jpn J Cancer Res, 76, pp. 43-52, (1985)
[9]  
Cline M.J., Battifora H., Yokota J., Proto-oncogene abnormalities in human breast cancer: correlation with anatomic features and clinical course of disease, J Clin Oncol, 5, pp. 999-1006, (1987)
[10]  
Kolata G., Oncogene gives breast cancer prognosis, Science, 235, pp. 160-161, (1987)